CC Chemours Co
Company Analysis
Latest News
π’ Chemours Co extends move to 5.1% up
CC is trading at $22.77, up 5.1% versus the comparison close of $21.67 during regular trading. This is a price-movement alert; no separate company-specific...
π’ Chemours Co is trading 4.4% up today after a technical rebound from yesterdayβs pullback
Chemours Co is trading at $22.63 (+4.43%) today, staging a technical rebound that reverses much of the 4.2% pullback seen on June 16. β’ The upward move...
π΄ Chemours Co is trading 4.2% down today in a pullback after recent gains
Chemours Co is trading 4.2% down at $21.50 today, giving back a portion of its strong multi-day run that saw the stock rise from $20.31 on June 10 to $22.43 on...
π’ Chemours Co is trading 5.2% up today after a U.S. court vacated an injunction on its business
Chemours Co is trading 5.2% up now at $21.37 after a U.S. federal appeals court vacated a preliminary injunction that had restricted parts of its business. β’...
π’ Chemours Co is trading 4.4% up today as court ruling vacates business injunction
Chemours Co is trading 4.4% up at $21.20 as the stock extends a multi-day recovery following a favorable U.S. federal appeals court decision. β’ The court...
π’ Chemours Co is trading 5.5% up today, continuing rebound after favorable court ruling
Chemours Co is trading at $21.43 (up 5.5%) in pre-market, continuing a rebound from recent lows, with the positive momentum appearing linked to a recent legal...
π΄ Chemours Co is trading 5.1% down today amid broad market risk-off selling
Chemours Co is trading 5.1% down at $19.80 today, moving lower alongside a broad U.S. equity sell-off as investors de-risk. β’ The decline aligns with general...
π΄ Chemours Co is trading 4.2% down today amid broader risk-off market pressure
Chemours Co is trading 4.2% down today at $19.98 amid a broader risk-off tone and weakness across U.S. equity markets. β’ No fresh company-specific headlines...
π΄ Chemours Co is trading 5.1% down today after court ruling on chemical discharges and market pullback
Chemours Co is trading 5.1% down at $20.57 following a federal appeals court decision regarding chemical discharges at its Washington Works facility. β’ The...
π΄ Chemours Co is trading 4.1% down today following a court ruling on chemical discharges and broader market pressure
Chemours Co is trading 4.1% down at $20.78 following a federal appeals court decision regarding chemical discharges and broader market volatility. β’ The stock...
π΄ Chemours Co is trading 5.2% down today as court overturns order to halt chemical discharges
Chemours Co is trading 5.2% down today at $21.43 after a federal appeals court overturned a prior ruling that had ordered the company to halt chemical...
π΄ Chemours Co is trading 5% down today as court overturns pollution discharge ruling
Chemours Co is trading 5% down at $21.48 after a federal appeals court overturned a ruling that had previously ordered the company to halt chemical discharges...
π΄ Chemours Co. is trading 4.1% down following a federal court ruling on Ohio River pollution
Chemours Co. is trading 4.1% down at $21.68 today, following a significant legal development regarding its operations. β’ On June 3, 2026, a federal appeals...
Chemours Rebounds 6.8% as Buyers Circle Back After a Brutal Post-Earnings Drop β But Can the Recovery Hold?
Shares of Chemours Co (CC) surged 6.8% to $23.84 on June 2, extending a multi-session bounce that has clawed back ground lost in a punishing post-earnings...
π’ Chemours Co is trading 6.8% up today extending rebound from post-earnings selloff
Chemours Co is trading at $23.84 (up 6.8%), continuing a multi-session recovery as investors reconsider the sharp selloff that followed its Q1 2026 earnings...
π’ Chemours Co is trading 3.6% up today
Chemours Co is trading at $23.12 (+3.61%), showing stock-specific strength despite a lack of clear company-specific headlines in the latest session. β’ The...
Chemours may avoid cleanup costs, as EPA reviews water standards
North Carolina environmental advocates are challenging an EPA decision to reconsider drinking water standards for PFAS compounds, including GenX. The...